Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    HomeNewsSunpharmaceuticalindustries

    Stock analysis is used by traders to make buy and sell call. It’s an approach to make informed decisions while investing in stocks. Stock analysis can be categorised into – fundamental analysis and technical analysis. Fundamental analysis is evaluation of data from sources, including financial records, economic reports, company assets, and market share. Analysts typically study the company’s financial statements – balance sheet, income statement, cash flow statement, and footnotes. These statements are made available to the investors in the form of quarterly earnings, disclosures to stock exchanges in compliance with the Securities and Exchange Board of India (Sebi) norms. In fundamental analysis, the analysts particularly check for a company's core income, income from other sources, profitability, guidance, assets and liabilities and debt ratio among other parameters. The other method, i.e. the technical analysis focuses purely on statistical data. It works on two assumptions; one, the stock price reflects the fundamentals. Second, the study of past and present movement in prices can help determine the future price trends. Technical analysis primarily deals with price, volume, demand and supply factors. This method is effective only when supply and demand forces influence the market. However, when outside factors are involved in a price movement, technical analysis may not be successful. More

    Jump to

    • Buy Castrol 420 Call, Dabur 290 Call: VK Sharma

      VK Sharma of HDFC Securities recommends buying Castrol India 420 Call and Dabur India 290 Call.

    • Buy DLF, Sun Pharma, Lupin: CA Rudramurthy BV

      CA Rudramurthy BV of Vachana Investments is of the view that one can buy DLF, Sun Pharma and Lupin.

    • Buy Sun Pharma, HDFC; sell Hexaware Technologies: Sukhani

      Sudarshan Sukhani of s2analytics.com is of the view that one can buy Sun Pharma and sell Hexaware Technologies.

    • Buy Sun Pharma; prefer Equitas Holdings: Kunj Bansal

      Kunj Bansal of Centrum Wealth Management is of the view that one can buy Sun Pharma and prefers Equitas Holdings.

    • Buy Sun Pharma; sell Just Dial, IOC: Ashwani Gujral

      Ashwani Gujral of ashwanigujral.com recommends buying Sun Pharma and advises selling Just Dial and IOC.

    • Here are top 10 stocks to focus on May 5

      Here are a few stocks picked up by CNBC-TV18's analysts to keep on your radar for trade today- SKS Microfinance, Sun Pharma, Orient Cement, Nucleus Software, Nelco, Carborundum Universal, Federal Bank, JSPL, Hexaware Tech, Bharat Forge, Ricoh India, Dewan Housing & Just Dial.

    • Cipla, favourite pick; like Sun Pharma: Pankaj Sharma

      Pankaj Sharma of Equirus Securities is of the view that Cipla is the favourite pick from the pharma space and likes Sun Pharma.

    • 'Glenmark to profit from drug price hike, +ve on Sun Pharma'

      The decision by Taro Pharma, Sun Pharma's Israeli subsidiary, to provide keveyis free of cost to distributors is likely to impact revenues of about USD 25 million, says Praful Bohra, VP Research at Religare.

    • Super 6 stocks that can give handsome returns on April 26

      Gaurav Bissa of LKP Securities is of the view that one can buy Ambuja Cements with a target of Rs 240 and Bata India with a target of Rs 575.

    • Here are top 10 stocks to focus on April 26

      CNBC-TV18's analysts gives stocks to keep on your radar for trade today - stocks expected to be under pressure today are ABB India, IPCA Labs, State Bank of Travancore, Sun Pharma, ITC, Godfrey Phillips and VST Industries while the stocks expected to gain are Indiabulls Housing, Bharti Airtel, Shilcar Tech, Novartis India and Excel Crop Care.

    • Exit Marksans Pharma, says Vijay Chopra

      Vijay Chopra of enochventures.com is of the view that one may exit Marksans Pharma.

    • Buy Sun Pharma, Bharat Forge: Rajat Bose

      Rajat Bose of rajatkbose.com is of the view that one can buy Sun Pharmaceutical Industries and Bharat Forge.

    • Prefer ICICI Bank, Cummins, Sun Pharma: Sharmila Joshi

      Sharmila Joshi of sharmilajoshi.com is of the view that one may prefer ICICI Bank, Cummins, HCL Technologies, Tech Mahindra and Sun Pharma.

    • Buy Sun Pharma 800 Put, says Rahul Shah

      Rahul Shah of Motilal Oswal is of the view that one can buy Sun Pharma 800 Put.

    • Positive on Jubilant Life Sciences, Aurobindo Pharma: Ajay Bodke

      Ajay Bodke of Prabhudas Lilladher has a positive view on Jubilant Life Sciences and Aurobindo Pharma.

    • Here are some stock picks from SP Tulsian

      In an interview of to CNBC-TV18's Latha Venkatesh and Sonia Shenoy, fundamental analyst, SP Tulsian of sptulsian.com shared his reading and outlook on the market and on various stocks.

    • Like Sun Pharma, Cipla, Glenmark Pharma: Deven Choksey

      Deven Choksey of KRChoksey Invst Managers likes Sun Pharmaceutical Industries, Cipla and Glenmark Pharma from the pharma space.

    • Buy Sun Pharma, BASF India, Ceat: Ashwani Gujral

      Ashwani Gujral of ashwanigujral.com is of the view that one can buy Sun Pharma, BASF India and Ceat.

    • Sell ONGC, Sun Pharma: Sudarshan Sukhani

      Sudarshan Sukhani of s2analytics.com is of the view that one can sell ONGC and Sun Pharma.

    • 6 stocks likely to see lot of action today

      Manas Jaiswal of manasjaiswal.com advises selling Cipla with a target of Rs 470.

    • Buy Tata Motors DVR, largecap pharma stocks: Parag Thakkar

      Parag Thakkar of HDFC Securities recommends buying Tata Motors DVR.

    • Sell pharma stocks; buy Hero Moto, Power Grid: Sudarshan Sukhani

      Sudarshan Sukhani of s2analytics.com recommends selling pharma stocks and advises buying Hero Motocorp and Power Grid.

    • Buy HPCL, sell Sun Pharmaceutical Industries: Rajat Bose

      Rajat Bose of rajatkbose.com recommends buying HPCL and advises selling Sun Pharmaceutical Industries.

    • Prefer Infosys, Kotak Mahindra Bank: Pankaj Jain

      According to Pankaj Jain of SW Capital, one may prefer Sun Pharma, Kotak Mahindra Bank and Infosys.

    • Like Glenmark Pharma, Sun Pharma: Deven Choksey

      Deven Choksey of KRChoksey Investment Managers likes Glenmark Pharma and Sun Pharma.

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347